The US Food and Drug Administration announced that Roche Remove breast cancer from the indicated of Avastin which it own production of anti-cancer drug in December 16, 2012. The reason is that the drug lack of evidence for safety and efficacy in the treatment of breast cancer.
FDA stressed that delete an indication for Avastin does not cause the drug from the market shelves, the drug may continue for the treatment of colon, kidney, lung and brain cancer. Avastin is a novel medicine that inhibits the growth of a network of blood vessels that supply nutrients and oxygen to cancerous tissues. Axitinib is a pill taken twice daily, while Avastin is given periodically by intravenous infusion. Avastin is a laboratory-produced molecule known as a monoclonal antibody that mimics the antibodies produced by the body’s immune system to defend against harmful substances. so that FDA announced avastin side effects breast cancer suggest to stop using. Almost three years ago, Avastin was shown in a major study to significantly prolong the time patients with breast cancer remain in remission. The most serious side effects associated with Avastin, in some cases resulting in death, are gastrointestinal perforation, wound healing complications, hemorrhage, and blood clots. In addition, the F. D. A. said that 71 percent of the women who got Avastin suffered from a serious side effect, compared with 51 percent of the women who got paclitaxel along.
FDA’s statement: they have assessed four clinical trials on breast cancer patients taking Avastin. Test data show that Avastin can not extend the life of patients with breast cancer and the effect of slowing tumor growth is limited.
However, its side effects are very obvious, the patient will have high blood pressure, heart disease, bleeding, stomach or intestinal perforation and other serious side effects.
Posts tagged ‘Avastin’
U. S. Food and Drug Administration (FDA) revoked the license for Avastin treat breast cancer. Avastin is an anti-cancer drug which was developed by the Roche Company. According to health Advisory Committees survey data for many years. The FDA says that it is considering withdrawal because Avastin doesn’t show enough promise against breast cancer. Most scientific experts consider this benefit “progression-free survival, ” sufficient for full approval, and many oncologists have been using Avastin as an “off-label” drug for this purpose And, unlike the case with the Avastin study completed by a prestigious NIH-funded consortium, the FDA should confidently rely on their results.
Avastin is a novel medicine that inhibits the growth of a network of blood vessels that supply nutrients and oxygen to cancerous tissues . Avastin (Bevacizumab, Avastin) is a recombinant humanized monoclonal antibody. Avastin currently is approved by the U. S. Food and Drug Administration (FDA) for treating lung and colon cancer, but many doctors use it to treat breast cancer. Avastin have serious side effects, Avastin also has serious, if infrequent, side effects, some of which can be lethal. The most serious side effects associated with Avastin, in some cases resulting in death, are gastrointestinal perforation, wound healing complications, hemorrhage, and blood clots. The FDA is also concerned that Avastin has bad side effects. Avastin was approved in 2008, listed on chemotherapy combination treatment Delay the growth of breast cancer five months. FDA studies have found Avastin only prolonged survival of patients with breast cancer to three months. but There is any evidence to prove to prolong survival of patients with advanced breast cancer.
Avastin is given periodically by intravenous infusion. Genentech produces two doses of Avastin, 100 and 400 milligrams, in the same size vial. The maximum tolerated dose of Avastin is not clear. The maximum dose tested in humans for the (20 mg / kg IV), 16 patients with headache in nine, including three severe headache, 1 times every 14 days. Avastin is not injected within 28 days after surgery, The incision Must completely healed, Before injected it. The most common adverse events in patients receiving Avastin included weakness, abdominal pain, headache, diarrhea, nausea and vomiting.
